A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBConor Tweed, Stephen H. Gillespie, Anna L. C. Bateson et al.|The International Journal of Tuberculosis and Lung Disease|2021Cited by 63
Age-specific nasal epithelial responses to SARS-CoV-2 infectionMaximillian Woodall, Claire M. Smith, Ana-Maria Cujba et al.|Nature Microbiology|2024Cited by 52
Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsisAntoine Villa, Fiona Dewar, Walter Pisciotta et al.|Critical Care|2025Cited by 1